LivaNova - Cardiovascular

When cardiopulmonary support or cardiac surgery are necessary, our advanced cardiovascular technologies can significantly improve patient outcomes. Our devices and systems are used in more than half of all open-heart surgeries worldwide. Our heart-lung machines have led the market for 40+ years, and we’re recognized as the number one cardiopulmonary bypass company worldwide. LivaNova is committed to continuous innovation with global R&D centers developing better technologies for heart conditions.